Stock Price
178.47
Daily Change
0.12 0.07%
Monthly
0.10%
Yearly
14.68%
Q2 Forecast
174.88

Masimo reported $400M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Accuray USD 150.96M 4.54M Dec/2025
Align Technology USD 214.94M 11.4M Mar/2026
AngioDynamics USD 65.57M 3.56M Sep/2025
Artivion USD 97.99M 5.57M Mar/2026
AtriCure USD 81.14M 2.65M Mar/2026
Avanos Medical USD 141.3M 6.7M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Boston Scientific USD 3.12B 174M Mar/2026
Dexcom USD 693.6M 64.5M Mar/2026
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
General Electric Aerospace USD 12.37B 499M Mar/2026
Globus Medical USD 772.6M 13.32M Mar/2026
Haemonetics USD 321.18M 15.02M Dec/2025
Inogen USD 25.08M 762K Sep/2025
Insulet USD 462.5M 9.9M Mar/2026
Integra LifeSciences USD 495.04M 2.3M Mar/2026
Intuitive Surgical USD 1.95B 105.1M Mar/2026
Masimo USD 400M 61.4M Mar/2026
Medtronic USD 6.31B 153M Dec/2025
Orthofix International USD 177.82M 5.5M Mar/2026
Owens Minor USD 65.28M 9.15M Mar/2026
ResMed USD 911.88M 10.17M Mar/2026
Steris USD 673.5M 15M Dec/2025
Stryker USD 5.42B 109M Mar/2026
Tandem Diabetes Care USD 126.4M 2.37M Mar/2026
Teleflex USD 380.86M 23.53M Mar/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026